The diagnostic significance and value of vestibular function testing combined with MRI in Meniere’s disease Authors: Yao Lu, Fei Gao, Yiming Zhu, Jiangyan Wang, Shujuan Li, Bo Gao, Xiaoye Pan, Xudong Wei Published: 2025 ABSTRACT AbstractObjectiveThis study aims to evaluate the diagnostic efficacy of electrocochleography (EcochG), vestibular evoked myogenic potentials (VEMPs), magnetic resonance imaging (MRI), and their combination in diagnosing Meniere’s disease (MD) by comparing these methods against established diagnostic standards. Using MRI as a reference for assessing the degree of endolymphatic hydrops (EH), this study analyzes the correlation between EH and each diagnostic method and assesses the ability of these methods to predict EH severity.MethodsA retrospective analysis was performed on 50 patients diagnosed with unilateral definite Meniere’s disease (DMD), which included functional vestibular examinations and MRI. All patients underwent testing for EcochG and VEMPs. The amplitudes of the summating potential (SP) and the cochlear nerve action potential (AP) were measured during the EcochG assessment. The VEMPs comprised cervical vestibular evoked myogenic potential (cVEMP) and ocular vestibular evoked myogenic potential (oVEMP), with bilateral amplitude ratios recorded. Abnormal findings were defined as a summating potential to action potential (SP/AP) ratio of ≥ 40% and/or a bilateral amplitude ratio greater than 1.61. This study also assessed the diagnostic accuracy of EcochG, VEMPs, MRI, and combined examinations for diagnosing unilateral DMD, along with their association with EH.ResultsA total of 50 patients (100 ears) were examined using relevant diagnostic methods. The positivity rate of EcochG was significantly lower than that of the other diagnostic methods (P < 0.05). Taking into account sensitivity, specificity, and AUC values comprehensively, the combined accuracy of EcochG, VEMPs, and MRI was significantly higher than that of the other diagnostic methods (P < 0.05). Additionally, we found that EcochG was negatively correlated with EH, whereas cVEMP was positively correlated with EH.ConclusionAlthough the combination of EcochG, VEMPs, and MRI demonstrates a lower positivity rate but higher specificity compared to other diagnostic test batteries, its overall diagnostic accuracy for diagnosing MD remains superior. Therefore, this combination holds significant diagnostic value in the evaluation of MD.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13005-025-00568-9.Keywords: Meniere's disease, Endolymphatic hydrops, Inner gadolinium, Electrocochleography, Vestibular evoked myogenic potentials Introduction Meniere’s disease (MD) is a chronic vestibular disorder that was first described by the French physician Prosper Menière in 1861. In 1938, Hallpike and Cairns documented the pathological changes in two cases of MD, noting significant dilation of the endolymphatic system, which primarily affects the cochlear duct and saccule [1]. The clinical manifestations of MD include episodic vertigo, fluctuating hearing loss, tinnitus, and aural fullness, with a prevalence ranging from 200 to 500 cases per 100,000 individuals [2]. The clinical manifestations of MD include episodic vertigo, fluctuating hearing loss, tinnitus, and aural fullness, with a prevalence ranging from 200 to 500 cases per 100,000 individuals. The pathogenesis of MD is widely believed to be associated with endolymphatic hydrops (EH), with four principal theories proposed to explain this association: membrane rupture, hydraulic fluctuations, ischemic episodes, and inflammation [3–5]. In addition, Jose A. Lopez-Escamez [6] reported that immunological and epigenetic mechanisms also contribute to endolymphatic hydrops. The literature suggests that the symptomatic profile of vestibular migraine (VM)—characterized by headache as well as vestibular and cochlear symptoms—resembles that of MD. Consequently, misdiagnosing MD as VM may result in inappropriate intensive treatments aimed at VM, which could cause unnecessary harm to the inner ear [7]. Collectively, these factors contribute to the ongoing diagnostic challenges associated with MD. In their study, So Young Kim et al. [8] proposed the hypothesis of a bidirectional and interrelated relationship between migraine and MD. This hypothesis posits that patients with MD have an increased risk of migraine; conversely, individuals with migraine also have a heightened risk of developing MD. Toshihisa Murofushi [9] studied patients exhibiting features of both conditions—a clinical presentation that cannot be classified solely as either entity. Furthermore, he investigated the hypothesis that this disease manifestation represents a genuine overlap syndrome—referred to as vestibular migraine and Meniere’s disease overlap syndrome (VM/MDOS)—with a shared pathophysiology, rather than being merely coincidental or comorbid. VM/MDOS is defined as a new clinical syndrome in which patients present with concurrent migrainous symptoms and episodic vertigo, accompanied by hearing loss and other cochlear manifestations. This clinical profile is believed to indicate a potential comorbidity of vestibular migraine and inner ear disease, including EH. In this study, we enrolled 50 patients with unilateral DMD who underwent comprehensive assessments, including pure-tone audiometry (PTA), inner-ear MRI, EcochG, and VEMPs. The objective was to investigate the correlations between individual and combined diagnostic modalities and EH, and to evaluate the diagnostic significance and clinical utility of these tests in MD. Methods Participants This study enrolled 55 patients with unilateral DMD diagnosed in the Department of Otolaryngology at our hospital between September 2024 and March 2025. Among them, 3 patients underwent cardiac surgery and 2 refused MRI examination, resulting in the inclusion of 50 consecutive patients (Fig. 1). Diagnostic criteria: (1) Two or more episodes of vertigo, each lasting 20 min to 12 h. (2) At least one audiometric assessment during the disease course demonstrating low- to mid-frequency sensorineural hearing loss in the affected ear. (3) Fluctuating aural symptoms (hearing loss, tinnitus, and/or aural fullness) in the affected ear. (4) Exclusion of vertigo due to other conditions, such as vestibular migraine, sudden sensorineural hearing loss, benign paroxysmal positional vertigo, labyrinthitis, vestibular neuritis, vestibular paroxysmia, drug-induced vertigo, posterior circulation ischemia, or intracranial mass lesions, among others. Inclusion criteria: (1) Meeting the 2015 American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) diagnostic consensus for MD. (2) Age ≥ 18 years. (3) Signed written informed consent. Exclusion criteria: (1) Presence of middle-ear disease. (2) History of prior ear surgery or invasive ear treatments (e.g., intratympanic gentamicin injection). (3) Contraindications to relevant examinations (e.g., claustrophobia). This study was conducted in accordance with clinical research ethics guidelines and was approved by the Ethics Committee of Gansu Provincial People’s Hospital. It was carried out in accordance with the World Medical Association Declaration of Helsinki. All participants provided written informed consent. Patient enrollment flowchart Audiovestibular function tests All patients underwent pure-tone audiometry (PTA), EcochG, and VEMPs testing on the day of consultation. On the same day, bilateral intratympanic administration of gadolinium contrast was performed, and the time of the last injection was recorded. MRI of the inner ear was performed 24 hours after the injection. Pure tone audiometry (PTA) All patients underwent pure-tone audiometry (PTA). A Madsen audiometer (Denmark) was used, and background noise level was maintained below 30 dB. Air- and bone-conduction thresholds at 125, 250, 500, 1000, 2000, 4000, and 8000 Hz were measured using an ascending–descending technique. The testing protocol adhered to the GB/T 16,403 − 1996 standard for audiometric testing methods. The pure-tone audiometry (PTA) value was calculated as the average air conduction threshold at frequencies of 500, 1000, 2000, and 4000 Hz. Staging of MD was based on the criteria established by the AAO-HNS [10], which classifies the condition into four stages according to the pure-tone average (PTA). Stage 1 corresponds to PTA ≤ 25 dB, Stage 2 corresponds to PTA between 26 and 40 dB, Stage 3 corresponds to PTA between 41 and 70 dB, and Stage 4 corresponds to PTA > 70 dB. Electrocochleography (EcochG) EcochG was performed on patients using the Vivosonic Integrity V500 system (Canada). Patients were positioned supine, and the test area was degreased. The reference electrode was positioned on the contralateral mastoid, while the ground electrode was placed on the nasion. Electrode impedance was maintained below 10 kΩ, with a bandpass filter setting ranging from 5 to 3000 Hz. The sweep analysis time was set to 10 ms, and each waveform was averaged over 1000 repetitions. The stimulus consisted of alternating clicks delivered at a repetition rate of 11.3 per second with an intensity of 90 dB nHL. Only reproducible waveforms were accepted for analysis. The SP/AP amplitude ratio was calculated, with a ratio of > 0.4 [11] considered abnormal. Vestibular evoked myogenetic potentials (VEMPs) Tone burst stimuli at 500 Hz, with a 1:2:1 envelope (one cycle rise and fall, followed by two plateau cycles), were delivered using insert earphones (Interacoustics Eclipse, Denmark). The initial stimulation intensity was set to 90 dB nHL, with threshold searching conducted in increments of 10 dB. The repetition rate was maintained at 4.9–5.1 Hz, and responses were averaged over 100 repetitions. Testing procedures adhered to the Chinese Expert Consensus on Clinical Practice for VEMPs Testing (2024) [12]. Tone-burst stimuli were used in all examinations. In cVEMP testing, the active electrode was placed on the skin surface overlying the sternocleidomastoid muscle, the reference electrode was positioned on the upper sternum, and the forehead served as the ground electrode. In oVEMP testing, the active electrode was placed on the chin, the reference electrode was positioned 1 cm below the lower eyelid, and the forehead served as the ground electrode. Patients were seated and performed head rotations during testing, which was conducted using tone-burst stimuli. VEMP latency and amplitude were recorded, and the interaural amplitude ratio (IAAR) and interaural asymmetry ratio(IAR) were calculated. An IAR greater than 0.40 or IAAR greater than 1.61 was considered abnormal [13]. MRI Under fiberoptic otoscopic guidance, a head and neck surgeon specializing in otolaryngology performed a trans-tympanic injection through the anteroinferior quadrant of the tympanic membrane. A diluted solution of gadoteric acid meglumine injection (Jiadixian, Beijing Huarun Shuanghe Pharmaceutical Co., Ltd., 15 mL containing 5.654 g of gadoteric acid meglumine) mixed with normal saline at a ratio of 1:7 was administered intratympanically, with an injection volume of 0.4 to 0.5 mL. Both ears received an injection of gadolinium-based contrast agent (GBCA), with the injected ear maintained in an upward position for 30 min prior to the injection of the contralateral ear. Eligible patients subsequently underwent 3D real-time axial scanning. Two radiologists independently evaluated the images, with any discrepancies resolved through consensus to establish the final interpretation. The scanning sequence and parameters were as follows: 3D real IR sequence parameters included TR of 8000 ms, TE of 315 ms, TI of 2250 ms, slice thickness of 0.7 mm, matrix of 256 × 256, field of view (FOV) of 160 mm × 160 mm, echo train length of 220, number of slices at 30, and a scan time of 5 min and 38 seconds. Endolymphatic hydrops (EH) MRI findings demonstrated low signal intensity (black) in the endolymphatic area and high signal intensity (white) in the perilymphatic area. The diagnostic criteria employed a visual scoring system, referencing Bernaerts’ 2019 grading method [13] (with an additional vestibular grade based on Baráth’s 2009 classification) [14]. Two experienced radiologists, blinded to clinical diagnoses, independently evaluated the images (Fig. 2). a In a patient diagnosed with right Meniere’s disease, fusion and enlargement of the right utricle and saccule are observed, indicating grade II endolymphatic hydrops (red arrow), while the right cochlear duct is widened (white arrow). b In a patient diagnosed with left Meniere’s disease, fusion and enlargement of the left utricle and saccule are observed, indicating grade III endolymphatic hydrops (red arrow), while the left cochlear duct is widened (white arrow) Vestibular grading (four Levels) Normal: Clearly separated saccule and utricle occupying less than half of the vestibular surface. Normal: Clearly separated saccule and utricle occupying less than half of the vestibular surface. Grade I: Saccule equal to or larger than the utricle without confluence. Grade I: Saccule equal to or larger than the utricle without confluence. Grade II: Confluence of the saccule and utricle with enhancement of the peripheral perilymphatic space. Grade II: Confluence of the saccule and utricle with enhancement of the peripheral perilymphatic space. Grade III: Disappearance of perilymphatic enhancement and complete obliteration of the bony vestibule. Grade III: Disappearance of perilymphatic enhancement and complete obliteration of the bony vestibule. Cochlear hydrops grading (three Levels) Normal: Identifiable interscalar septum, scala tympani, and scala vestibuli. Normal: Identifiable interscalar septum, scala tympani, and scala vestibuli. Grade I: Widened cochlear duct with a visible but reduced scala vestibuli. Grade I: Widened cochlear duct with a visible but reduced scala vestibuli. Grade II: Widened cochlear duct with non-visible scala vestibuli. Grade II: Widened cochlear duct with non-visible scala vestibuli. Statistical analysis All statistical analyses in this study were conducted using SPSS Statistics software (Version 27.0; IBM Corp.). Continuous variables were assessed for normality with the Shapiro-Wilk test. Normally distributed variables are presented as the mean ± standard deviation and are compared between groups using the independent samples t-test. Non-normally distributed variables are expressed as the median (interquartile range) and compared using the Mann-Whitney U test. Categorical variables are summarized as number (percentage) and compared between groups using either the chi-square test or Fisher’s exact test, as appropriate. The correlation between variables was analyzed using Spearman’s rank correlation. To evaluate the diagnostic performance of the variables, receiver operating characteristic (ROC) curves were constructed, and the area under the curve (AUC), sensitivity, specificity, positive predictive value, and negative predictive value were calculated. All tests were two-tailed, and a P-value of < 0.05 was considered statistically significant. Results Patients This study enrolled 50 patients (100 ears) with unilateral DMD, comprising 23 males and 27 females, with a mean age of 53 years and an average hearing level of 41.69 dB. All 50 patients (100%) presented with vertigo, while 45 patients (90%) reported tinnitus, 5 patients (10%) experienced aural fullness, and 2 patients (4%) manifested Tumarkin attacks. Manon Bachelet et al. [11] collected data from 39 patients, including 30 with DMD. Among these 30 DMD patients, 30/30 (100%) experienced vertigo, 25/30 (83%) reported tinnitus, and 1 out of 30 patients (3.3%) had Tumarkin attacks. The distribution of symptoms generally aligns with trends observed in previous studies. However, it is important to note that differences in study centers and the size of patient cohorts are significant factors influencing the prevalence rates of these symptoms. Audiovestibular function tests All patients underwent EcochG, VEMPs, and MRI examinations on the day of their visit. As shown in Table 1, the positive rate for EcochG was 64% (32/50), with both cVEMP and oVEMP demonstrating abnormal interaural amplitude ratios. The MRI demonstrated the highest positive rate of 90% among individual tests. The results for combined testing modalities were as follows: EcochG + VEMPs showed an 88% positive rate, EcochG + MRI indicated a 98% positive rate, VEMPs + MRI also indicated a 98% positive rate, and EcochG + VEMPs + MRI displayed an 84% positive rate. The positive rate of EcochG was significantly lower than that of other examination methods (P < 0.05). In summary, among individual tests, MRI exhibited the highest detection rate at 90%, whereas among combined tests, both EcochG + MRI and VEMPs + MRI achieved the highest positive rates of 98%. However, the triple combination of EcochG + VEMPs + MRI yielded the lowest detection rate. Table 1Comparison of positive rates of various examination methodsExamination methods N results (positive/negative)positive ratesEcochG5032/1864.00MRI5045/590.00EcochG + VEMPs5044/688.00EcochG + MRI5049/198.00VEMPs + MRI5049/198.00EcochG + VEMPs + MRI5042/884.00 Comparison of positive rates of various examination methods 1、Table 2 shows that among the individual examinations, MRI exhibits the highest sensitivity. Among the combined examinations, both EcochG + MRI and VEMPs + MRI demonstrate the highest sensitivity. EcochG + MRI has the lowest specificity, whereas EcochG + VEMPs + MRI has the highest specificity. Table 2Diagnostic results of various examination methodsexamination methodsAUCsensitivityspecificityPositive predictiverateNegative predictiverateEcochG0.6600.6400.6800.6670.654MRI0.7900.9000.6800.7380.872EcochG+ VEMPs0.6900.8800.5000.6380.806EcochG + MRI0.6900.9800.4000.6200.952VEMPs + MRI0.7400.9800.5000.6620.962EcochG + VEMPs + MRI0.8600.8400.8800.8750.846 Diagnostic results of various examination methods 2、As shown in Fig. 3, compared with the diagnostic criteria, the diagnostic efficacy of MRI is higher than that of EcochG (AUC = 0.79). Additionally, the diagnostic accuracy of EcochG + VEMPs + MRI is significantly better than that of other examinations (P < 0.05). A comparison of the area under the receiver operating characteristic curve (AUC) for the diagnostic efficacy of various examination methods in relation to the international diagnostic standard Endolymphatic hydrops (EH) Among the 50 patients in this series, 42 were diagnosed with EH, including 15 cases (30%) of mild vestibular hydrops (VH), 9 cases (18%) of severe VH, 17 cases (34%) of mild cochlear hydrops (CH), and 2 cases (4%) of severe CH (Table 3). In the contralateral asymptomatic ears, 8 cases exhibited EH, 25 cases demonstrated positive SP/AP ratios, and 17 cases showed abnormalities in VEMPs. Table 3 Distribution and severity of hydrops in vestibular and cochlear compartmentsendolymphatic hydrops N Proportion(%)Mild vestibular hydrops1530Severe vestibular hydrops918Mild cochlear hydrops1734Severe cochlear hydrops24 Distribution and severity of hydrops in vestibular and cochlear compartments We analyzed the correlation between VH and CH and found that VH showed a significant correlation with the stage of MD (P < 0.01), while CH was correlated with the stage of MD (P < 0.05) (Table 4). We subsequently explored the correlation between various examination methods and EH. The results presented in Figs. 4 and 5 indicate that VH showed a significant negative correlation with EcochG (r = −0.378, P = 0.007), a significant positive correlation with cVEMP (r = 0.376, P = 0.007), and not significant correlation with oVEMP (r = −0.151, P = 0.295). Furthermore, Figs. 6 and 7 demonstrate that CH was significantly negatively correlated with EcochG (r = −0.321, P = 0.023), significantly positively correlated with cVEMP (r = 0.311, P = 0.028), and not significantly correlated with oVEMP (r = −0.095, P = 0.512). Table 4Correlation between Meniere's disease stages and the degree of endolymphatic hydropsVHCHstage of MD0.581** 0.338* *indicates P<0.05**indicates P<0.0***indicates P<0.001 Correlation between Meniere's disease stages and the degree of endolymphatic hydrops *indicates P<0.05 **indicates P<0.0 ***indicates P<0.001 Correlation between vestibular hydrops and electrocochleography Correlation between vestibular hydrops and cVEMP Correlation diagram between cochlear hydrops and electrocochleography Correlation diagram between cochlear hydrops and cVEMP Based on the previous examination results used to determine whether patients are affected by the disease, we investigated the potential to predict the occurrence of EH. Fig. 8 shows that the area under the receiver operating characteristic curve (AUC) of EcochG for vestibular hydrops (VH) is 0.702 (CI, 0.479–0.926), while the AUC of cVEMP for VH is 0.665 (CI, 0.482–0.848). Fig. 9 indicates that the AUC of EcochG for cochlear hydrops (CH) is 0.671 (CI, 0.513–0.830), and the AUC of cVEMP for CH is 0.664 (CI, 0.501–0.826). These data suggest that EcochG exhibits a certain predictive capability for EH. ROC curve chart for the occurrence of vestibular hydrops ROC curve chart for the occurrence of cochlear hydrops Discussion This study aimed to investigate the diagnostic efficacy of individual and combined examination modalities for MD in comparison to international diagnostic criteria, as well as to explore their correlation with EH for predictive purposes. Our results demonstrated that MRI exhibited the highest diagnostic positivity rate (90%) among functional vestibular tests. The combined approach of EcochG, VEMPs, and MRI demonstrated superior accuracy compared to the individual modalities of EcochG combined with VEMPs or EcochG combined with MRI alone. This finding is consistent with literature that suggests the clinical utility of multimodal diagnostic tools [15]. However, further validation with larger sample sizes is necessary to confirm its sensitivity and specificity. Additionally, we examined the correlation between the stages of MD and EH and found that EH is positively correlated with MD stages. Previous studies have investigated the correlation between the stages of MD and EH. Leticia et al. [16]. determined that there is a correlation between the stages of MD and EH based on the observed damage to the vestibule and cochlea at different MD stages. However, some literature indicates that there is no correlation between EH and MD [17]. Existing literature has drawn inconsistent conclusions regarding the correlation between EcochG, VEMPs, and EH. Some studies have found that EcochG is correlated with EH, while VEMPs are not correlated with EH. Conversely, other studies suggest that both EcochG and cVEMP are correlated with EH, whereas some studies argue that neither is correlated [17–20]. In light of the discrepancies in the aforementioned conclusions, we propose several possible explanations. First, heterogeneity may exist in the included data due to regional variations, individual differences, and methodological disparities in measurement. Second, from a pathophysiological perspective and in light of previous research [21], as the disease progresses to more advanced stages, the EcochG component may become distorted due to the deterioration of cochlear hair cells. Furthermore, while the cVEMP response to air-conducted stimulation originates from the saccule and is thus sensitive to EH in the saccule, the oVEMP response is sensitive to EH in the utricle. However, the utricle is generally not involved in the early to middle stages of MD. Finally, this study constructed ROC curves to evaluate the predictive value of EcochG and cervical cVEMP for EH. The results confirmed their significant predictive capability. Furthermore, Grigol et al. reported that cVEMP could predict involvement of the contralateral asymptomatic ear [22]. This study investigated the diagnostic value of EcochG, VEMPs, and MRI in MD. Additionally, the caloric test is of particular importance in the evaluation of MD. Although the interpretation of caloric testing during MD attacks remains controversial, a clinical trial conducted by Sun-Uk Lee [23]. involving 46 MD patients found that caloric responses fluctuate both during and between attacks, depending on the electrophysiological status of the vestibular afferent nerves. According to the literature, caloric testing may be more effective than video head impulse testing (vHIT) in detecting vestibular function abnormalities across MD [24]. In addition, we found that among 50 patients with unilateral MD, 5 cases showed negative results on MRI. Combining these findings with previous studies, the observed negative results may be attributed to individual differences in the permeability of the round window membrane and the varying grading criteria for EH employed in the research [25, 26]. This study also found that EH was present in 8 asymptomatic ears. Additionally, among the contralateral asymptomatic ears, 25 patients showed positive findings on EcochG, while 15 patients demonstrated positive results on VEMPs. It is well established that MD can progress to bilateral involvement after several years [27]. According to research reports, the formation of EH begins with an increase in endolymphatic pressure, which does not immediately result in dilation of the membranous labyrinth. However, this pressure elevation can induce disturbances within the cochlea [11]. Furthermore, a study conducted by Carlos Guajardo-Vergara et al. [28] that utilized MRI as the diagnostic reference investigated the impact of vestibular function tests and pure-tone audiometry on MD. The results demonstrated that responses in the unaffected ear were not affected by the presence or severity of EH, thus elucidating the phenomenon of positive test results in the contralateral asymptomatic ear. It is important to note that the VEMPs examination relies on bilateral comparison, which prevents the distinction of results between the affected ear and the contralateral asymptomatic ear. This limitation also explains why VEMPs were not evaluated separately in the section of this study discussing diagnostic efficacy. Previous studies have primarily focused on the correlation between the degree of hearing loss, vestibular function tests, and EH, as well as the discrepancies in the diagnosis of MD resulting from different MRI sequences. The novelty of this study lies in the comparison of various examination methods to identify the combination that demonstrates the highest diagnostic efficacy for MD. Subsequently, a ROC curve is generated through correlation analysis to predict the occurrence of EH, an achievement that has not yet been documented in the existing literature. Interestingly, we found that the predictive accuracy of CH for the occurrence of VH is 70.2%, while the predictive accuracy of CH for the occurrence of CH is 67.1%. This finding provides significant advantages for patients who are unable to undergo MRI examinations. Certainly, the occurrence of EH still requires verification through inner ear MRI. Furthermore, this study included oVEMP, whereas most previous studies predominantly employed examination methods such as the video head impulse test or otoacoustic emissions, or focused exclusively on cVEMP indicators. It is important to note that the positivity rate of oVEMP is very low and that no correlation with EH has been established. Murofushi et al. [29]reported that, compared to the normal control group, there were no significant differences in the amplitude and threshold of conventional ocular VEMP values in patients with MD, concluding that hydrops does not significantly impact this test. This conclusion aligns with the findings of the present study. Additionally, from a regional replication perspective, systematically validates and implements a comprehensive diagnostic workflow integrating vestibular function assessment (VEMPs, EcochG) with inner ear structural evaluation (gadolinium-enhanced MRI) within a single-center Chinese and Asian population. We emphasize that the feasibility and diagnostic efficacy of this cross-modal workflow in routine clinical settings require further validation across diverse contexts. While large-scale studies have established the principle, its successful adaptation to specific environments with varying resources, patient populations, and clinical routines constitutes a valuable contribution. Our work provides real-world evidence and practical experience to support the broader adoption of this integrated approach. We specifically demonstrate how our research concretely bridges functional testing with MRI imaging; for instance, we show how to correlate EH patterns on MRI with the degree of functional test abnormalities. This combined workflow holds potential advantages for enhancing diagnostic accuracy and optimizing individualized patient management. The limitations of this study are as follows: (1) The absence of a control group comprising normal or non-MD patients represents a key limitation. As the required inner ear MRI protocol involves an invasive gadolinium injection, the contralateral ear served as the internal control. Consequently, the direct applicability of our findings to differential diagnosis is limited, and the diagnostic accuracy reported herein may not be fully generalizable to routine clinical practice. (2) This study did not employ quantitative or semi-quantitative grading systems for EH assessment, which introduced a degree of subjectivity into the evaluation outcomes. (3) The relatively small sample size in this study may introduce biases into the research conclusions. (4) No correction for multiple comparisons was applied in the statistical analyses. Future studies with larger cohorts are needed to validate these findings and explore the potential influences of additional variables, such as disease duration, age, and gender. 5.This study was restricted to the AAO-HNS diagnostic criteria and did not include a comparative analysis with the Japanese diagnostic standards. Conclusion In conclusion, this study has effectively demonstrated the diagnostic value of MRI, VEMPs, and EcochG for MD, as well as the predictive value of EcochG and cVEMP for EH. Furthermore, EcochG, VEMPs, and MRI have confirmed not only the pathological effects of MD on the affected ear but also the occurrence of endolymphatic pressure disturbances in the asymptomatic contralateral ear, for which the specific pathophysiological mechanisms require further investigation. Supplementary Information Supplementary Material 1. Authors’ contributions Y. L: Data curation & Writing – original draft & Formal analysis Software F. G: Supervision & Writing – review and editing Y.M. Z: Supervision & Writing – review and editing J.Y.W.: Data curation & Supervision S.J. L: Data curation & Supervision B. G: Data curation & Supervision & Visualization X.Y. P: Data curation & Supervision Visualization X.D. W: Writing – original draft & Writing – review and editing & Supervision. Funding The authors declare no financial interests in the present study and have no potential conflicts of interest to disclose. The data in this study are clinical in nature and therefore cannot be publicly disclosed. Data availability Data involving patient privacy is not applicable. Declarations Ethics approval and consent to participate The ethical committee of Gansu Provincial People’s Hospital approved this study (2025 − 517). All patients signed informed consent forms prior to participating in the clinical study. Consent for publication I confirm that I have obtained consent from all participants for the publication of the content of this paper. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement Data involving patient privacy is not applicable.